Alzheimer's drug donanemab lowers risk of dementia
Donanemab is expected to receive FDA approval after a trial linked it to a 40% lower risk of progressing from mild cognitive impairment to mild dementia.
Source: nypost.com
Page 8 - Aging Center News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Aging Center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Aging Center Today - Breaking & Trending Today
Donanemab shows promise in slowing Alzheimer's disease
With yet a third new Alzheimer's drug expected to be approved by the Food and Drug Administration (FDA), the field is beginning to show progress in the fight to slow the disease.
Source: news-medical.net
Amprion's αSynuclein Seed Amplification Assay to be Showcased at Alzheimer's Association International Conference® 2023 (AAIC®)
/PRNewswire/ -- Amprion, a global leader in the advancement of neurodegenerative disorder diagnosis, will be in attendance at the Alzheimer's Association...
Source: prnewswire.com
How a rare dementia transforms patients into artists
UCSF-led research reveals brain changes that promote visual creativity.
Source: universityofcalifornia.edu
Can humans stop ageing?
As researchers continue to examine the causes of ageing, some seek ways to stop it altogether.
Source: aljazeera.com